Rare diseases
Investigational molecules
Locations
Back to Germany578 clinical trials in Ulm, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GermanyGermanyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on colorectal cancer, acute myeloid leukemia, and various types of lymphomas. Studies are evaluating novel combination therapies and targeted treatments for patients with specific genetic mutations.
Multiple trials investigating innovative treatment approaches for blood cancers and solid tumors.
Clinical research targeting multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis. Studies are exploring new therapeutic agents and diagnostic tools.
Innovative approaches in neurodegenerative disease management and treatment.
Comprehensive studies on inflammatory bowel diseases, rheumatoid arthritis, and Sjögren's disease. Research focuses on novel biological therapies and long-term treatment options.
Advanced therapeutic approaches for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
